- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | May 25, 2018
Clinical News
Janssen discontinues two Alzheimer's trials for BACE inhibitor
BioCentury | May 4, 2018
Clinical News
Merck's verubecestat reduces beta amyloid levels but fails to improve cognition, function
BioCentury | Mar 4, 2017
Product Development
Diagnosing AD trials
Why diagnostics are key to the development of AD drugs
Items per page:
1 - 10 of 19